Business Context and Reporting Period
Company: MetLife, Inc.
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2026
Business Overview: MetLife is a global financial services company providing insurance, annuities, employee benefits, and asset management. In Q4 2025, the company executed a "Strategic Reorganization," establishing MetLife Investment Management (MIM) as a distinct reportable segment and reclassifying MetLife Holdings into Corporate & Other. The company operates through six segments: Group Benefits, Retirement and Income Solutions (RIS), Asia, Latin America, EMEA, and MIM.
Key Financial Metrics
| Metric (Six Months Ended June 30, 2026) | Value ($ millions) | YoY Change |
|---|---|---|
| Total Revenues | 38,228 | +6.5% |
| Net Income (GAAP) | 1,941 | +15.2% |
| Net Income Available to Common Shareholders | 1,845 | +17.0% |
| Adjusted Earnings Available to Common Shareholders | 3,159 | +16.5% |
| Net Investment Income | 12,057 | +14.3% |
| Net Investment Gains (Losses) | (1,098) | Worsened |
| Net Derivative Gains (Losses) | (698) | Worsened |
| Total Assets | 759,372 | +1.9% (vs. Dec 31, 2025) |
| Total Liabilities | 731,411 | +2.1% (vs. Dec 31, 2025) |
| Stockholders' Equity | 27,441 | -3.4% (vs. Dec 31, 2025) |
| Cash and Cash Equivalents | 19,301 | -12.4% (vs. Dec 31, 2025) |
| Long-Term Debt | 14,244 | -1.5% (vs. Dec 31, 2025) |
Material Changes vs. Prior Period
- Profitability Growth: Net income available to common shareholders increased by $268 million (17.0%) compared to the six months ended June 30, 2025. This was driven primarily by higher adjusted earnings, favorable market risk benefit (MRB) remeasurement, and a lower effective tax rate (24% vs. 28% in the prior year).
- Investment Performance: Net investment income rose significantly due to higher yields on fixed income securities and positive flows from pension risk transfer transactions. However, net investment losses widened to $1.1 billion (from $660 million) due to higher losses on sales of fixed maturity securities, foreign currency transaction losses, and real estate impairments.
- Derivative Impact: Net derivative losses increased to $698 million (from $364 million) primarily due to the strengthening U.S. dollar against the Japanese yen and rising long-term swap rates.
- Segment Performance: Adjusted earnings increased across all major segments. Group Benefits saw a $171 million increase driven by favorable mortality results. RIS increased $52 million due to market factors. Asia and Latin America benefited from volume growth and favorable foreign currency impacts.
- Balance Sheet: Total assets grew to $759.4 billion. Cash and cash equivalents decreased by $2.7 billion, largely due to investing activities and share repurchases.
Guidance, Outlook, and Risks
- Strategic Reorganization: The company continues to integrate the MIM segment following the Q4 2025 reorganization. The acquisition of PineBridge Investments in late 2025 is driving revenue growth in the MIM segment.
- Divestiture: MetLife entered a definitive agreement in Q2 2026 to sell its wholly-owned subsidiary, MetLife Ukraine. An impairment loss of $65 million (net of tax) was recorded. The transaction is expected to close in 2027.
- Capital Actions: The company repurchased $1.5 billion of common stock in the first six months of 2026. On August 5, 2026, the Board authorized an additional $3.0 billion in common stock repurchases.
- Key Risks:
- Market Volatility: Sensitivity to interest rate changes, equity market performance, and foreign currency exchange rates (particularly the Japanese yen and Latin American currencies).
- Credit Risk: Exposure to credit losses in the mortgage loan portfolio and fixed maturity securities, though the portfolio remains predominantly investment-grade.
- Regulatory & Legal: Ongoing litigation, including asbestos-related claims and the Total Asset Recovery Services qui tam action regarding unclaimed property reports.
- Reinsurance: Risks related to reinsurer creditworthiness and the potential shortfall of risk mitigants.
Investor Verification Checklist
- Verify Adjusted Earnings Reconciliation: Confirm the adjustments made to GAAP net income to arrive at Adjusted Earnings, specifically regarding net investment gains/losses and derivative impacts.
- Review Mortgage Loan ACL: Examine the rollforward of the Allowance for Credit Loss (ACL) on mortgage loans, which increased to $1.36 billion, and the specific provisions for commercial and residential segments.
- Assess MetLife Ukraine Disposition: Monitor the progress of the pending sale of MetLife Ukraine and any potential additional impairments or tax impacts prior to the expected 2027 closing.
- Check Derivative Hedging Effectiveness: Review the impact of the strengthening U.S. dollar and rising interest rates on the fair value of derivative positions and MRBs.
- Confirm Capital Return Capacity: Verify the company's ability to sustain the new $3.0 billion share repurchase authorization alongside dividend payments, considering regulatory restrictions on subsidiary dividends.